Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation

Vaccine. 2007 Sep 4;25(36):6635-45. doi: 10.1016/j.vaccine.2007.06.036. Epub 2007 Jul 10.

Abstract

We evaluated the effectiveness of in vivo electroporation (EP) for the enhancement of immune responses induced by DNA plasmids encoding the pre-erythrocytic Plasmodium yoelii antigens PyCSP and PyHEP17 administered intramuscularly and intradermally to mice. EP resulted in a 16- and 2-fold enhancement of antibody responses to PyCSP and PyHEP17, respectively. Immunization with 5 microg of DNA via EP was equivalent to 50 microg of DNA via conventional needle, thus reducing by 10-fold the required dose to produce a given effect. Moreover, IFN-gamma responses were increased by approximately 2-fold. Data demonstrate the potential of EP to enhance immune responses to DNA vaccines against infectious agents.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Antibodies, Protozoan / immunology*
  • Antigens, Protozoan / genetics
  • Antigens, Protozoan / immunology
  • Electroporation / methods*
  • Female
  • Immunity, Cellular / immunology*
  • Immunization / methods
  • Injections, Intradermal
  • Injections, Intramuscular
  • Interferon-gamma / immunology*
  • Liver / immunology
  • Liver / parasitology
  • Malaria Vaccines / administration & dosage
  • Malaria Vaccines / immunology*
  • Mice
  • Mice, Inbred BALB C
  • Plasmids / genetics
  • Plasmodium yoelii / genetics
  • Plasmodium yoelii / immunology
  • Vaccines, DNA / administration & dosage
  • Vaccines, DNA / genetics
  • Vaccines, DNA / immunology*

Substances

  • Antibodies, Protozoan
  • Antigens, Protozoan
  • Malaria Vaccines
  • Vaccines, DNA
  • Interferon-gamma